Cargando…

Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) have the ability of differentiating into functional cardiomyocytes (CMs) for cell replacement therapy, tissue engineering, drug discovery and toxicity screening. From a scale-free, co-expression network analysis of transcr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Maggie Zi-Ying, Sadrian, Stephanie N., Keung, Wendy, Geng, Lin, Ren, Lihuan, Kong, Chi-Wing, Wong, Andy On-Tik, Hulot, Jean-Sebastien, Chen, Christopher S., Costa, Kevin D., Hajjar, Roger J., Li, Ronald A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522495/ https://www.ncbi.nlm.nih.gov/pubmed/31097748 http://dx.doi.org/10.1038/s41598-019-42953-w

Ejemplares similares

Withdrawal: MicroRNA-7 compromises p53-dependent apoptosis by controlling the expression of the chromatin remodeling factor SMARCD1
por: Hong, Chun-Fu, et al.
Publicado: (2021)

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
por: Hulot, Jean-Sébastien, et al.
Publicado: (2014)

Non-cell autonomous cues for enhanced functionality of human embryonic stem cell-derived cardiomyocytes via maturation of sarcolemmal and mitochondrial K(ATP) channels
por: Keung, Wendy, et al.
Publicado: (2016)

SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes
por: Inoue, Chisato, et al.
Publicado: (2017)

LncRNA SMARCD3-OT1 Promotes Muscle Hypertrophy and Fast-Twitch Fiber Transformation via Enhancing SMARCD3X4 Expression
por: Zhang, Jing, et al.
Publicado: (2022)

Correlation between frataxin expression and contractility revealed by in vitro Friedreich’s ataxia cardiac tissue models engineered from human pluripotent stem cells
por: Wong, Andy On-Tik, et al.
Publicado: (2019)

Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1
por: Zhu, Yihao, et al.
Publicado: (2020)

Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy
por: McGeachie, Michael J., et al.
Publicado: (2020)

SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms
por: Saha, Subha, et al.
Publicado: (2022)

Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells
por: Hazeltine, Laurie B., et al.
Publicado: (2012)

Development of a Contractile Cardiac Fiber From Pluripotent Stem Cell Derived Cardiomyocytes
por: Hansen, Katrina J., et al.
Publicado: (2018)

Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues
por: Wong, Andy On-Tik, et al.
Publicado: (2021)

Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
por: Feaster, Tromondae K., et al.
Publicado: (2021)

Fractalkine Depresses Cardiomyocyte Contractility
por: Taube, David, et al.
Publicado: (2013)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: Tanaka, Atsushi, et al.
Publicado: (2014)

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
por: Jiang, Ming, et al.
Publicado: (2020)

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
por: Ferguson, L. Paige, et al.
Publicado: (2023)

Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women
por: Zhou, Qiu-Hong, et al.
Publicado: (2014)

MBRS-63. THE ROLE OF THE SWI/SNF COMPLEX SUBUNIT SMARCD3 IN MEDULLOBLASTOMA
por: Poore, Brad, et al.
Publicado: (2020)

Correction: Fractalkine Depresses Cardiomyocyte Contractility
por: Taube, David, et al.
Publicado: (2013)

Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism
por: Boyd, John H, et al.
Publicado: (2008)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016)

Effectiveness of gene delivery systems for pluripotent and differentiated cells
por: Rapti, Kleopatra, et al.
Publicado: (2015)

A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis
por: Zou, Han, et al.
Publicado: (2023)

3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs
por: Stillitano, Francesca, et al.
Publicado: (2019)

The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark
por: Fasano, Candida, et al.
Publicado: (2023)

An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
por: Wang, Ruiying, et al.
Publicado: (2019)

Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes
por: Saleem, Umber, et al.
Publicado: (2020)

Approaches to High-Throughput Analysis of Cardiomyocyte Contractility
por: Wright, Peter T., et al.
Publicado: (2020)

Extracellular Matrix in Regulation of Contractile System in Cardiomyocytes
por: Bildyug, Natalya
Publicado: (2019)

microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
por: Tamai, Motoki, et al.
Publicado: (2022)

Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations
por: Ibrahim, Abukhiran, et al.
Publicado: (2022)

Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With Hypoplastic Left Heart Syndrome
por: Kim, Min-Su, et al.
Publicado: (2020)

Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy
por: Ito, Masamichi, et al.
Publicado: (2020)

Correction: An integrated characterization of contractile, electrophysiological and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes
por: Wang, Ruiying, et al.
Publicado: (2023)

Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues
por: Cheng, Shangli, et al.
Publicado: (2023)

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives
por: Chow, Maggie Zi, et al.
Publicado: (2013)

Vinculin anchors contractile actin to the cardiomyocyte adherens junction
por: Merkel, Chelsea D., et al.
Publicado: (2019)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

Smyd1b is required for skeletal and cardiac muscle function in zebrafish
por: Li, Huiqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q4rcdqr4ng7not6fhefp1g1205